Giovanna Cutrona
Overview
Explore the profile of Giovanna Cutrona including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
1522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nano E, Reggiani F, Amaro A, Monti P, Colombo M, Bertola N, et al.
Noncoding RNA
. 2024 Sep;
10(5).
PMID: 39311383
A "watch and wait" strategy, delaying treatment until active disease manifests, is adopted for most CLL cases; however, prognostic models incorporating biomarkers have shown to be useful to predict treatment...
2.
Mazzarello A, Gugiatti E, Cossu V, Bertola N, Bagnara D, Carta S, et al.
Cancer Immunol Immunother
. 2024 Jan;
73(2):27.
PMID: 38280019
Chronic lymphocytic leukemia (CLL) is a disease of the elderly, often presenting comorbidities like osteoporosis and requiring, in a relevant proportion of cases, treatment with bisphosphonates (BPs). This class of...
3.
Giannoni P, Marini C, Cutrona G, Sambuceti G, Fais F, de Totero D
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894425
Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in Western countries. Although characterized by the progressive expansion and accumulation of leukemic B cells in peripheral blood, CLL cells develop...
4.
Morabito F, Adornetto C, Monti P, Amaro A, Reggiani F, Colombo M, et al.
Front Oncol
. 2023 Sep;
13:1198992.
PMID: 37719021
Analyzing gene expression profiles (GEP) through artificial intelligence provides meaningful insight into cancer disease. This study introduces DeepSHAP Autoencoder Filter for Genes Selection (DSAF-GS), a novel deep learning and explainable...
5.
Morabito F, Tripepi G, Mauro F, Laurenti L, Reda G, Moia R, et al.
Am J Hematol
. 2023 Apr;
98(7):E157-E160.
PMID: 37067157
No abstract available.
6.
Giannoni P, Marini C, Cutrona G, Todoerti K, Neri A, Ibatici A, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497460
Significant skeletal alterations are present in Chronic Lymphocytic Leukemia (CLL) patients; bone erosion, particularly evident in the long bone shaft, appeared increased in the progressive disease stage. Moreover, the partial...
7.
Bagnara D, Mazzarello A, Ghiotto F, Colombo M, Cutrona G, Fais F, et al.
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430731
The engagement of the B cell receptor (BcR) on the surface of leukemic cells represents a key event in chronic lymphocytic leukemia (CLL) since it can lead to the maintenance...
8.
De Luca G, Cerruti G, Lastraioli S, Conte R, Ibatici A, Di Felice N, et al.
Hematol Oncol
. 2022 Aug;
40(5):962-975.
PMID: 35961859
Chronic lymphocytic leukemia (CLL) is a hematological disorder with complex clinical and biological behavior. TP53 mutational status and cytogenetic assessment of the deletion of the corresponding locus (17p13.1) are considered...
9.
Bagnara D, Colombo M, Reverberi D, Matis S, Massara R, Cardente N, et al.
Front Oncol
. 2022 Jul;
12:894419.
PMID: 35837088
Chronic Lymphocytic Leukemia (CLL) is characterized by the accumulation of monoclonal CD5 B cells with low surface immunoglobulins (IG). About 40% of CLL clones utilize quasi-identical B cell receptors, defined...
10.
Matis S, Grazia Recchia A, Colombo M, Cardillo M, Fabbi M, Todoerti K, et al.
Blood Adv
. 2022 Jul;
6(20):5593-5612.
PMID: 35819446
Chronic lymphocytic leukemia (CLL) cells express the interleukin-23 receptor (IL-23R) chain, but the expression of the complementary IL-12Rβ1 chain requires cell stimulation via surface CD40 molecules (and not via the...